Cargando…
Vitamin D, zinc and glutamine: Synergistic action with OncoTherad immunomodulator in interferon signaling and COVID-19 (Review)
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in December, 2019 in Wuhan, China. Since then, it has continued to spread rapidly in numerous countries, while the search for effective therapeutic options persists. Coronaviru...
Autores principales: | Name, José João, Vasconcelos, Andrea Rodrigues, Souza, Ana Carolina Remondi, Fávaro, Wagner José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834962/ https://www.ncbi.nlm.nih.gov/pubmed/33448317 http://dx.doi.org/10.3892/ijmm.2021.4844 |
Ejemplares similares
-
Zinc, Vitamin D and Vitamin C: Perspectives for COVID-19 With a Focus on Physical Tissue Barrier Integrity
por: Name, José João, et al.
Publicado: (2020) -
Impact of an educational programme on Alzheimer’s disease patients’ quality of life: results of the randomized controlled trial THERAD
por: Villars, Hélène, et al.
Publicado: (2021) -
Antioxidant and anti-inflammatory mechanisms of action of astaxanthin in cardiovascular diseases (Review)
por: Pereira, Carolina Parga Martins, et al.
Publicado: (2021) -
Predictors of nursing home placement at 2 years in Alzheimer's disease: A follow‐up survey from the THERAD study
por: Villars, Hélène, et al.
Publicado: (2022) -
Unveiling the Potential of BenzylethyleneAryl–Urea Scaffolds for the Design of New Onco Immunomodulating Agents
por: Gil-Edo, Raquel, et al.
Publicado: (2023)